Detalhe da pesquisa
1.
Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors.
Bioorg Med Chem Lett
; 30(7): 126986, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32046903
2.
Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virus.
Bioorg Med Chem
; 28(1): 115208, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740203
3.
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061289
4.
Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29180522
5.
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29084747
6.
Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir.
J Med Virol
; 90(1): 109-119, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842997
7.
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193664
8.
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir.
Antimicrob Agents Chemother
; 59(9): 5445-54, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100711
9.
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitor.
Antimicrob Agents Chemother
; 59(3): 1505-11, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534735
10.
In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.
Antimicrob Agents Chemother
; 59(2): 988-97, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25451053
11.
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.
PLoS One
; 13(10): e0205186, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286205
12.
Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection.
Viruses
; 10(9)2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154359
13.
Phenotypic analysis of T-cells in extensive alopecia areata scalp suggests partial tolerance.
J Invest Dermatol
; 126(2): 366-73, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16374469